| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $46.2M | — | +3.3% |
| Cost of Revenue | $39.0M | — | +10.3% |
| Gross Profit | $7.2M | — | -23.2% |
| R&D Expense | $6.7M | — | +12.8% |
| SG&A Expense | $7.7M | — | -21.1% |
| Operating Income | -$7.2M | — | -14.0% |
| Pre-tax Income | -$6.6M | — | -20.5% |
| Income Tax | -$1.9M | — | -375.8% |
| Net Income | -$4.6M | — | +47.7% |
| EPS (Basic) | -$0.13 | — | +45.8% |
| EPS (Diluted) | -$0.13 | — | +45.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $94.6M | -8.9% | -28.7% |
| Accounts Receivable | $24.2M | -7.1% | -14.5% |
| Inventory | $32.8M | -3.8% | +0.7% |
| Current Assets | $170.0M | -3.9% | -21.1% |
| Total Assets | $335.5M | -4.6% | -10.3% |
| Current Liabilities | $71.7M | +65.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2K | — | +100.0% |
| Capital Expenditures | $4K | — | -98.1% |
| Investing Cash Flow | -$6K | — | +98.5% |
| Financing Cash Flow | -$320 | — | +100.0% |
| Free Cash Flow | -$2K | — | +100.0% |
| +50.1% |
| Long-term Debt | $42.3M | -5.2% | +55.0% |
| Total Liabilities | $102.7M | -0.6% | -1.9% |
| Stockholders' Equity | $232.8M | -6.2% | -13.5% |